Jiujie Cui

机构：Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes · ORCID：0000-0003-0853-7569

发表论文 210 篇 · 总被引 3351 次 · h-index 31

代表论文

• Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib (2024 · Molecular Cancer · 被引 41)
• Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 29)
• Upregulation of Lactobacillus spp . in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects (2025 · Gut Microbes · 被引 27)
• Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma (2024 · EMBO Molecular Medicine · 被引 24)
• An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy (2024 · Cancer Letters · 被引 21)
• CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment (2025 · Journal for ImmunoTherapy of Cancer · 被引 17)